Browsing Immunology by Author "Navari, Rudolph M."

Now showing items 1-2 of 2

2023 updated MASCC/ESMO consensus recommendations : prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting

Rapoport, Bernardo Leon; Herrstedt, Jorn; Snow, Rebecca Clark; Radhakrishnan, Venkatraman; Saito, Mitsue; Navari, Rudolph M.; Smit, Teresa (Springer, 2024-01)

PURPOSE : This review is an update of the MASCC/ESMO 2015 recommendations for the prophylaxis of acute and delayed nausea and vomiting induced by multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea ...
Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy

Navari, Rudolph M.; Rapoport, Bernardo Leon; Powers, Dan; Arora, Sujata; Clark-Snow, Rebecca (Wiley Open Access, 2018-07)

Most patients receiving highly or moderately emetogenic chemotherapy experience chemotherapy-induced nausea and vomiting without antiemetic prophylaxis. While neurokinin-1 receptor antagonists (NK-1RAs) effectively ...

Now showing items 1-2 of 2

Search UPSpace